Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid Malaria Test Assessed for Field Use

By LabMedica International staff writers
Posted on 13 Dec 2012
Rapid diagnostic tests (RDT) for malaria infections could replace light microscopy in poor resource locations as their ease of use and accuracy are improved. More...


Although light microscopy (LM) is the gold standard for malaria diagnosis it is not available in many outlying health facilities and is time consuming, requires highly trained personnel and needs careful preparation and application of reagents to ensure quality results.

Scientists at the University of Gondar (Ethiopia) collected blood samples from 254 patients suspected to have malaria at a health center in Northwestern Ethiopia in the late malaria transmission-peak season from November 2011 to December 2011. The male to female ratio was 1.57:1, while the mean age of the participants was 21.4 years with an age range of 5 months to 75 years. Most of the participants were from rural areas of the district. The samples were examined immediately by light microscopy (LM) and the RDT.

The overall parasite positivity using LM was 104 (40.9%): 40 (15.7%) for Plasmodium falciparum, 58 (22.8%) for P. vivax and six (2.4%) had mixed infections. The CareStart RDT gave an overall parasite positivity of 100 (39.4%) with 50 (19.7%) for P. falciparum, 24 (9.5%) for P. vivax and 26 (10.2%) for mixed infections. Difference in detection of P. falciparum parasites using either the LM or the RDT was insignificant, but difference in detection of P. vivax using the LM and RDT was found to be significant.

The CareStart Malaria COMBO Test kit (Diasys Ltd.; New York, NY, USA) is a three-band RDT detecting histidine-rich protein 2 (HRP-2) and PAN- lactate dehydrogenase (pLDH) and results are obtained in 20 minutes. The test has an overall sensitivity of 95% and specificity of 94.2%. The sensitivity and specificity for mixed infections and non-falciparum malaria was slightly less. The authors concluded that the CareStart RDT test showed good sensitivity and specificity with an excellent agreement to the reference light microscopy. The RDT could therefore be used in place of microscopy, which in poor set-ups cannot be used routinely. The full study is available since in November 2012 in the Malaria Journal.

Related Links:
University of Gondar
Diasys Ltd.



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.